Population pharmacokinetics of lopinavir and ritonavir in combination with rifampicin-based antitubercular treatment in HIV-infected children.
about
Factors Associated with the Development of Drug Resistance Mutations in HIV-1 Infected Children Failing Protease Inhibitor-Based Antiretroviral Therapy in South AfricaSimultaneous population pharmacokinetic modelling of atazanavir and ritonavir in HIV-infected adults and assessment of different dose reduction strategies.Model-based evaluation of the pharmacokinetic differences between adults and children for lopinavir and ritonavir in combination with rifampicinPotential drug-drug interactions in HIV-infected children on antiretroviral therapy in Lagos, Nigeria.Pharmacokinetic behavior presents drug therapy challenges.Tackling virological failure in HIV-infected children living in Africa.Antiretroviral treatment in HIV-infected children who require a rifamycin-containing regimen for tuberculosis.Population Pharmacokinetics of Lopinavir in Severely Malnourished HIV Infected Children and the Effect on Treatment Outcomes.
P2860
Q28546698-3930CA23-78FA-4A8B-9C3F-786AB821FF83Q36675895-C232B880-708C-45C0-9332-BDE7D99ADBF5Q37369323-E8C03641-A147-4F69-977B-02B908F9047AQ37696834-C5564ECE-CEB2-43BC-9A32-5FC50D8421F6Q38155930-B0F3AF59-A212-43ED-915C-113D0259C4B7Q38552894-2A0697ED-C479-472A-ACCA-DBF584901CF9Q38874266-74996D56-AE2B-4E53-BDA1-108F1353A908Q49949305-790573D2-B28D-4C46-82AC-4095613294AF
P2860
Population pharmacokinetics of lopinavir and ritonavir in combination with rifampicin-based antitubercular treatment in HIV-infected children.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Population pharmacokinetics of ...... ment in HIV-infected children.
@en
Population pharmacokinetics of ...... ment in HIV-infected children.
@nl
type
label
Population pharmacokinetics of ...... ment in HIV-infected children.
@en
Population pharmacokinetics of ...... ment in HIV-infected children.
@nl
prefLabel
Population pharmacokinetics of ...... ment in HIV-infected children.
@en
Population pharmacokinetics of ...... ment in HIV-infected children.
@nl
P2093
P2860
P50
P356
P1433
P1476
Population pharmacokinetics of ...... tment in HIV-infected children
@en
P2093
Chao Zhang
Jan-Stefan van der Walt
Mats O Karlsson
P2860
P356
10.3851/IMP1915
P577
2012-01-01T00:00:00Z